Grifols, S.A. (ADR)
General ticker "GRFS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.8B (TTM average)
Grifols, S.A. (ADR) follows the US Stock Market performance with the rate: 58.7%.
Estimated limits based on current volatility of 2.6%: low 8.50$, high 8.98$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-08-12, amount 0.14$ (Y3.15%)
- Total employees count: 157 as of 2010
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.14$, 13.07$]
- 2025-12-31 to 2026-12-31 estimated range: [9.97$, 15.37$]
Short-term GRFS quotes
Long-term GRFS plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | €7,212.38MM |
| Operating Expenses | €6,020.37MM |
| Operating Income | €1,192.02MM |
| Non-Operating Income | €-748.02MM |
| Interest Expense | €773.15MM |
| R&D Expense | €384.04MM |
| Income(Loss) | €444.00MM |
| Taxes | €231.19MM |
| Profit(Loss)* | €156.92MM |
| Stockholders Equity | €5,883.73MM |
| Inventory | €3,560.10MM |
| Assets | €21,405.24MM |
| Operating Cash Flow | €902.17MM |
| Capital expenditure | €371.37MM |
| Investing Cash Flow | €886.67MM |
| Financing Cash Flow | €-1,358.71MM |
| Earnings Per Share** | €0.23 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.